Sort
130,381 grants matching “hiv”
Centralized HIV-1 Genes as Vaccines
$1,071,043Duke University · P01 · FY2005 · AI
Core A: Administrative Core
$1,071,027Alan Edward Greenberg · George Washington University · P30 · FY2016 · AI
Cellular Mechanisms Of Xenobiotic Transport
$1,071,017David Miller · Environmental Health Sciences · Z01 · FY2007 · ES
The National Drug Abuse Clinical Trials Network: New England Consortium Node
$1,070,985Gail D'onofrio · Yale University · UG1 · FY2022 · DA
HIV PREVENTION PROJECTS
$1,070,872Jennifer Brown · Utah State Department Of Health · U62 · FY2006 · PS
VETERINARY/ANIMAL CARE SERVICES
$1,070,868D. Rick Lee · Charles River Laboratories Intntl, Inc. · N02 · FY2011 · RR
Efficacy and cost of HAART DOT in methadone clinics
$1,070,849Julia H. Arnsten · Albert Einstein College Of Medicine · R01 · FY2006 · DA
Development of an Ad5 [E1-, E2b-] HIV-1 vaccine for use in Ad5 Immunized Vaccinee
$1,070,762Frank R. Jones · Etubics Corporation · R44 · FY2009 · AI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
$1,070,697Tracy Fischer · Temple Univ Of The Commonwealth · P01 · FY2017 · MH
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
$1,070,498Timothy W Schacker · University Of Minnesota · U01 · FY2016 · AI
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
$1,070,482Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AI
Antiviral Activity In Situ
$1,070,231Georgia D Tomaras · Duke University · P01 · FY2024 · AI
Medical Retina Fellowship
$1,070,068Catherine Cukras · National Eye Institute · ZIE · FY2023 · EY
TRANSITION TO LOCAL OWNERSHIP AND INTEGRATION OF HIV PROGRAMS IN PRIMARY HEALTH C
$1,070,000Izukanji Sikazwe · Centre For Infectious Disease Research · U2G · FY2015 · GH
Long Acting Film Technology for Contraception and HIV Prevention (LATCH)
$1,069,972Lisa C Rohan · Magee-Women'S Res Inst And Foundation · R33 · FY2023 · AI
Recombinant Adenovirus Vector Vaccine Studies
$1,069,851Gary J Nabel · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Interaction of HIV envelope with cell surface receptors
$1,069,830Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$1,069,830Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s)
$1,069,648Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
HIV-1 Reverse Transcriptase
$1,069,644Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Developmental
$1,069,586Ann Cornwall Collier · University Of Washington · P30 · FY2008 · AI
UCSF Older Americans Independence Center
$1,069,324Kenneth E. Covinsky · University Of California, San Francisco · P30 · FY2020 · AG
Strengthening Translational Research in Diverse Enrollment (STRIDE)
$1,069,260Stephenie C. Lemon · Univ Of Massachusetts Med Sch Worcester · U01 · FY2016 · TR
DRUG USERS IN NEW YORK AND PUERTO RICO--HIV RISK BEHAVIO
$1,069,217National Development &Res Institutes · R01 · FY2002 · DA
The Role Of Innate Immunity Genes In Viral Infection and Disease Progression
$1,069,024Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES